References of "REGINSTER, Jean-Yves"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailRational to use OSIRIS® (osteoporosis index of risk) to prescreen for osteoporosis in the general population
Richy, Florent; Gourlay, M.; Ethgen, Olivier ULg et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 67-68

Detailed reference viewed: 28 (0 ULg)
Full Text
Peer Reviewed
See detailOral monthly ibandronate decrease bone turnover in postmenopausal women with low bone mass: results from the monthly oral pilot study (MOPS)
Reginster, Jean-Yves ULg; Wiese, C.; Wilson, K. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 5

Detailed reference viewed: 38 (0 ULg)
Full Text
Peer Reviewed
See detailPhysical function is the most severely impaired health-related quality of life dimension during the aging process
Ethgen, Olivier ULg; Gosset, Christiane ULg; Richy, Florent et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 65

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailComparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis
Reginster, Jean-Yves ULg; Adachi, J. R.; Qu, Y. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 42

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailImpact of osteoarthritis and chronic back pain on health-related quality of life among patients on NSAIDS
Rabenda, Véronique ULg; Ethgen, Olivier ULg; Belaiche, Jacques ULg et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 89-90

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailProspective evaluation of health-related quality of life in total hip and knee arthroplasties
Ethgen, Olivier ULg; Tancredi, Annalisa ULg; Brugneaux, C. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 66

Detailed reference viewed: 5 (2 ULg)
Full Text
Peer Reviewed
See detailEffects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a chinese population
Xu, Ling; Liu, Jianli; Lin, Jingfang et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 97-98

Detailed reference viewed: 38 (1 ULg)
Full Text
Peer Reviewed
See detailAssessment of the risk of cardiovascular diseases in women with increased risk of osteoporosis
Tancredi, Annalisa ULg; Bosio-Le Goux, B.; Reginster, Jean-Yves ULg

in Osteoporosis International (2003, November), 14(Suppl. 7), 89

Detailed reference viewed: 6 (0 ULg)
Full Text
Peer Reviewed
See detailThe robustness of the relation between risk factors for osteoporosis and risk factors for cardiovascular diseases in postmenopausal women increases with age
Bosio-Le Goux, B.; Cortet, B.; Lopes, P. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 98

Detailed reference viewed: 27 (1 ULg)
Full Text
Peer Reviewed
See detailDo patient with osteoporotic hip fracture recover their initial health-related quality of life?
Ethgen, Olivier ULg; Tancredi, Annalisa ULg; Jacques, J. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 66

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women without prevalent vertebral fracture
Reginster, Jean-Yves ULg; Balogh, A.; Badurski, J. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 7-8

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailEconomic evaluation of OSIRIS® (osteoporosis index of risk), a prescreening tool for prediction of osteoporosis risk, using decision trees and Markov models
Combescure, C.; Daures, J. P.; Chevallier, T. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 88

Detailed reference viewed: 14 (2 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis
Reginster, Jean-Yves ULg; Lorenc, R. S.; Spector, Tim D et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 51-52

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailBMD in men: which normative data?
Richy, Florent; Gourlay, M.; Ethgen, Olivier ULg et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 66-67

Detailed reference viewed: 12 (0 ULg)
Full Text
Peer Reviewed
See detailHigh prevalence of risk factors for cardiovascular diseases in postmenopausal women being prescribed an antiosteoporotic treatment
Bosio Le Goux, B.; Augendre-Ferrante, B.; Tancredi, Annalisa ULg et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 87

Detailed reference viewed: 17 (2 ULg)
Full Text
Peer Reviewed
See detailProspective validation in 798 postmenopausal women of a new screening tool for osteoporosis risk assessment: OSIRIS® (osteoporosis index of risk)
Reginster, Jean-Yves ULg; Viethel, P.; Micheletti, M. C. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 94

Detailed reference viewed: 9 (2 ULg)